Protagenic Therapeutics, Inc.\new Adjustments to Additional Paid in Capital, Warrant Issued
Protagenic Therapeutics, Inc.\new (PTIX) reported Adjustments to Additional Paid in Capital, Warrant Issued of $20.43 thousand for the 12-month period ending 2022-12-31, per its 10-K/A filed 2024-05-14.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2024-05-14
- Protagenic Therapeutics, Inc.\new adjustments to additional paid in capital, warrant issued for the quarter ending 2022-03-31 was $20.43K.
- Protagenic Therapeutics, Inc.\new adjustments to additional paid in capital, warrant issued for the quarter ending 2020-06-30 was $86.97K.
- Protagenic Therapeutics, Inc.\new adjustments to additional paid in capital, warrant issued for the quarter ending 2020-03-31 was $5.86K.
- Protagenic Therapeutics, Inc.\new adjustments to additional paid in capital, warrant issued for fiscal 2022 was $20.43K.
- Protagenic Therapeutics, Inc.\new adjustments to additional paid in capital, warrant issued for fiscal 2020 was $107.67K.
- Protagenic Therapeutics, Inc.\new adjustments to additional paid in capital, warrant issued for fiscal 2017 was $99.78K.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 3 month | Adjustments to Additional Paid in Capital, Warrant Issued 6 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month |
|---|---|---|---|
| 2022-12-31 | $20.43K 10-K/A · filed 2024-05-14 | ||
| 2022-03-31 | $20.43K 10-Q · filed 2023-11-14 | ||
| 2020-12-31 | $107.67K 10-K · filed 2022-04-07 | ||
| 2020-06-30 | $86.97K 10-Q · filed 2021-11-15 | $92.83K derived: sum of 2 quarters · filed 2021-11-15 | |
| 2020-03-31 | $5.86K 10-Q · filed 2020-11-16 | ||
| 2017-12-31 | $99.78K 10-K · filed 2019-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |